Assessment of the Relationship between Hypnotics and Delirium Using the Japanese Adverse Drug Event Report (JADER) Database

被引:2
|
作者
Kikuchi, Norikazu [1 ]
Hazama, Katsuyuki [2 ]
Imai, Toru [2 ]
Suzuki, Shinichiro [2 ]
Yoshida, Yoshikazu [2 ]
Hidaka, Shinji [3 ]
机构
[1] Nihon Univ Hosp, Dept Pharm, Chiyoda Ku, 1-6 Surugadai, Tokyo 1018309, Japan
[2] Nihon Univ, Itabashi Hosp, Dept Pharm, Itabashi Ku, 30-1 Oyaguchikami Machi, Tokyo 1738610, Japan
[3] Nihon Univ, Sch Pharm, Dept Pharmaceut Regulatory Sci, 7-7-1 Narashinodai, Funabashi, Chiba 2748555, Japan
关键词
The Japanese Adverse Drug Event Report; reporting odds ratio; delirium; CRITICALLY-ILL PATIENTS; RECEPTOR; METAANALYSIS; ASSOCIATION; POPULATION; RAMELTEON;
D O I
10.1248/yakushi.17-00221
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Japanese Adverse Drug Event Report (JADER) database was used to examine the risk of delirium and the time of its onset with various hypnotics, including 10 benzodiazepines (BZDs), 3 non-benzodiazepines (non-BZDs), 1 melatonin receptor agonist (MRTA), and 1 orexin receptor inhibitor (OXRI). Data entered in the JADER database between April 1, 2004 and February 1, 2016 were analyzed. The index for safety signal detection, the reporting odds ratio (ROR), was the odds ratio for adverse drug reaction reporting. The ROR for each drug was calculated; a signal was considered present if the lower bound of the 95 % confidence interval of the ROR was greater than 1. The time to onset of delirium was calculated for drugs for which the number of days from the start of drug administration to delirium onset was reported. During the period examined in the analysis, a total of 621114 adverse drug reaction reports were seen, and the total number of delirium reports was 1417 after redundant cases were excluded. A signal was detected for 5 of the 10 BZDs and all 3 non-BZDs, with no signal for the MRTA and the OXRI. The time of delirium onset varied widely even for drugs classified as being in the same action duration group, and no correlation was seen for delirium onset time. The results of this study suggested that delirium risk varies depending on the hypnotic. Thus, hypnotics can be selected according to their delirium risk.
引用
收藏
页码:985 / 990
页数:6
相关论文
共 50 条
  • [21] A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis
    Fujiwara, Masakazu
    Kawasaki, Yohei
    Yamada, Hiroshi
    PLOS ONE, 2016, 11 (04):
  • [22] Exploring Adverse Event Reporting Patterns of Newly Approved Anti-Cancer Drugs in the Japanese Adverse Drug Event Report (JADER) Database
    Matsuda, Shinichi
    Hamada, Kenji
    Aoki, Kotonari
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 282 - 283
  • [23] Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
    Shimada, Kazuyo
    Hasegawa, Shiori
    Nakao, Satoshi
    Mukai, Ririka
    Sasaoka, Sayaka
    Ueda, Natsumi
    Kato, Yamato
    Abe, Junko
    Mori, Takayuki
    Yoshimura, Tomoaki
    Kinosada, Yasutomi
    Nakamura, Mitsuhiro
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (09): : 1295 - 1303
  • [24] Risk of delirium with antiepileptic drug use: a study based on the Japanese Adverse Drug Event Report database
    Kubo, Toshiki
    Sogawa, Rintaro
    Tsuruhashi, Satoko
    Murakawa-Hirachi, Toru
    Matsuoka, Ayaka
    Mizoguchi, Yoshito
    Monji, Akira
    Shimanoe, Chisato
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (05) : 1260 - 1266
  • [25] Risk of delirium with antiepileptic drug use: a study based on the Japanese Adverse Drug Event Report database
    Toshiki Kubo
    Rintaro Sogawa
    Satoko Tsuruhashi
    Toru Murakawa-Hirachi
    Ayaka Matsuoka
    Yoshito Mizoguchi
    Akira Monji
    Chisato Shimanoe
    International Journal of Clinical Pharmacy, 2023, 45 : 1260 - 1266
  • [26] Risk Factors for Pseudoaldosteronism with Yokukansan Use: Analysis Using the Japanese Adverse Drug Report (JADER) Database
    Ishida, Tomoaki
    Kawada, Kei
    Morisawa, Shumpei
    Jobu, Kohei
    Morita, Yasuyo
    Miyamura, Mitsuhiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (10) : 1570 - 1576
  • [27] Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database
    Anzai, Tatsuhiko
    Takahashi, Kunihiko
    Watanabe, Michiko
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2019, 73 (01) : 27 - 33
  • [28] Analysis of urinary retention caused by selective β3-adrenoceptor agonists using the Japanese Adverse Drug Event Report database (JADER)
    Kawazoe, T.
    Ishida, T.
    Jobu, K.
    Kawada, K.
    Yoshioka, S.
    Miyamura, M.
    PHARMAZIE, 2023, 78 (05): : 56 - 62
  • [29] Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database
    Oura, Mitsuaki
    Oguro, Fumiya
    Agatsuma, Nobukazu
    Imamaki, Hirotaka
    Nishikawa, Yoshitaka
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (01) : 7 - 14
  • [30] Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database
    Mitsuaki Oura
    Fumiya Oguro
    Nobukazu Agatsuma
    Hirotaka Imamaki
    Yoshitaka Nishikawa
    Cancer Chemotherapy and Pharmacology, 2023, 92 : 7 - 14